FINHUB Insights

IQV · Q3 FY25 · Jul 1 – Sep 30, 2025

IQVIA Q3 FY25: where the revenue came from and where it went

IQVIA Q3 FY25: revenue $4.1B (+5% year over year). Net profit $0.3B. Largest cohort Research and Development $2.3B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jul 1 – Sep 30, 2025
Reported
Oct 28, 2025 10-Q
Sankey diagram of IQVIA's income statement for Q3 FY25: revenue of $4.1 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$4.1B +5% year over year
Gross profit$1.4B 33% margin
Operating profit$0.6B 13% margin
Net profit$0.3B 8% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
ItemValueShare of revenueYear over year
Revenue 4.1 100% +5%
Research and Development 2.3 56% +5%
Technology and Analytics 1.6 39% +5%
Contract Sales and Medical 0.2 5% +16%
Cost of revenue−2.766%
Gross profit1.433% margin+10pp
SG&A−0.513%−1pp
Other−0.37%+0pp
Operating profit0.613% margin−1pp
Tax−0.2
Interest & other costs−0.1
Net profit0.38%+1pp
Filing on EDGAR More quarters of IQV

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters